European Healthtech startup funding raised during Q2 2023.
In Q2 2023, 130 European Healthtech companies raised a combined €1.3B across 132 funding rounds, down 30.7% versus Q2 2022. France led by capital raised, and European Innovation Council (EIC) was the most active investor. Data as of 23 Aug 2026.
| €74M |
| Complement Therapeutics | Series A | Apr 2023 | €72M |
| Corwave | Series C | Jun 2023 | €61M |
| Moon Surgical | Other | May 2023 | €51M |
| Tissium | Series D+ | May 2023 | €50M |
| NewBiologix | Series A | May 2023 | €46M |
| Arthex Biotech | Series B | May 2023 | €42M |
| VarmX | Series B | May 2023 | €30M |
| Woodoo | Other | Apr 2023 | €28M |
| NVision Imaging | Series A | Jun 2023 | €28M |
| DiogenX | Series A | May 2023 | €28M |
| Gleamer | Series B | Jun 2023 | €27M |
